Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.710
-0.060 (-3.39%)
At close: Feb 27, 2026, 4:00 PM EST
1.720
+0.010 (0.58%)
After-hours: Feb 27, 2026, 7:51 PM EST

Autolus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4556251,120329378468
Market Cap Growth
-12.75%-44.17%240.67%-13.12%-19.06%-21.26%
Enterprise Value
4132691,057233227343
Last Close Price
1.712.356.441.905.198.94
PS Ratio
8.9061.80659.6951.70162.43272.63
PB Ratio
1.711.4610.051.101.212.23
P/TBV Ratio
1.861.5110.051.101.212.23
EV/Sales Ratio
8.0826.63622.4836.6997.51199.84
Debt / Equity Ratio
1.230.702.010.500.220.26
Net Debt / Equity Ratio
-0.16-0.68-0.14-0.78-0.77-0.47
Net Debt / EBITDA Ratio
0.161.250.091.711.840.61
Net Debt / FCF Ratio
0.151.270.101.891.910.75
Asset Turnover
0.070.020.000.010.010.01
Quick Ratio
5.5210.485.908.8711.795.44
Current Ratio
6.1910.886.159.1812.155.86
Return on Equity (ROE)
-60.56%-81.91%-101.61%-48.64%-54.30%-61.13%
Return on Assets (ROA)
-22.99%-25.99%-25.35%-19.94%-25.07%-35.16%
Return on Capital Employed (ROCE)
-47.30%-33.40%-53.10%-32.20%-37.20%-64.50%
Earnings Yield
-49.40%-35.28%-18.60%-45.27%-37.55%-30.39%
FCF Yield
-62.67%-36.51%-13.98%-37.45%-33.48%-28.33%
Buyback Yield / Dilution
-14.65%-46.69%-83.11%-31.78%-39.81%-19.72%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q